Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
<p><strong>Background</strong><br> For blood-stage malaria vaccine development, the in vitro growth inhibition assay (GIA) has been widely used to evaluate functionality of vaccine-induced antibodies (Ab), and <em>Plasmodium falciparum</em> reticulocyte-binding pr...
主要な著者: | Miura, K, Diouf, A, Fay, MP, Barrett, JR, Payne, RO, Olotu, AI, Minassian, AM, Silk, SE, Draper, SJ, Long, CA |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BioMed Central
2023
|
類似資料
-
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
著者:: Kazutoyo Miura, 等
出版事項: (2023-05-01) -
Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
著者:: Douglas, A, 等
出版事項: (2014) -
Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria
著者:: Partey, F, 等
出版事項: (2018) -
Targeting PfRh5 on Merozoites to Prevent Basigin Binding
著者:: Papadopoulos Konstantinos
出版事項: (2012-10-01) -
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants
著者:: Bustamante, L, 等
出版事項: (2013)